Literature DB >> 19906050

Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man.

Danica Juricic1, Juricic Danica, Irena Hrstic, Hrstic Irena, Davor Radic, Radic Davor, Mate Skegro, Skegro Mate, Marijana Coric, Coric Marijana, Boris Vucelic, Vucelic Boris, Igor Francetic, Francetic Igor.   

Abstract

Vanishing bile duct syndrome is a severe cholestatic disease associated with toxic effects of medications. Stevens-Johnson syndrome is a hypersensitivity disorder that may also be caused by medications. We present a case of a 62-year-old male patient who developed vanishing bile duct syndrome a month after Stevens-Johnson syndrome. These adverse drug reactions were associated with the use of azithromycin (500 mg daily for 3 days). The patient was initially treated for Stevens-Johnson syndrome with steroids, antihistamines and proton pump inhibitors and fully recovered. However, a month after the beginning of Stevens-Johnson syndrome, he developed vanishing bile duct syndrome and was treated with steroids, ursodeoxycholic acid, antihistamines and tacrolimus. Unfortunately, the treatment was unsuccessful and he was listed for liver transplantation which was performed 7 months after the beginning of jaundice. This is the first case of vanishing bile duct syndrome associated with the use of azithromycin and one of few that reports vanishing bile duct syndrome and Stevens-Johnson syndrome co-occurrence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906050     DOI: 10.1111/j.1742-7843.2009.00474.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  11 in total

1.  Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.

Authors:  Matthew Mason; Oyedele Adeyi; Scott Fung; Barbara-Ann Millar
Journal:  BMJ Case Rep       Date:  2014-11-28

2.  Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.

Authors:  Harshad Devarbhavi; Guruprasad Aithal; Sombat Treeprasertsuk; Hajime Takikawa; Yimin Mao; Saggere M Shasthry; Saeed Hamid; Soek Siam Tan; Cyriac Abby Philips; Jacob George; Wasim Jafri; Shiv K Sarin
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

3.  Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.

Authors:  Herbert L Bonkovsky; David E Kleiner; Jiezhun Gu; Joseph A Odin; Mark W Russo; Victor M Navarro; Robert J Fontana; Marwan S Ghabril; Huiman Barnhart; Jay H Hoofnagle
Journal:  Hepatology       Date:  2017-02-07       Impact factor: 17.425

4.  Clinical and histologic features of azithromycin-induced liver injury.

Authors:  Melissa A Martinez; Raj Vuppalanchi; Robert J Fontana; Andrew Stolz; David E Kleiner; Paul H Hayashi; Jiezhun Gu; Jay H Hoofnagle; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-09       Impact factor: 11.382

5.  Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.

Authors:  Ana Paula Oppenheimer; Christopher Koh; Mary McLaughlin; John C Williamson; Thomas D Norton; Jennifer Laudadio; Theo Heller; David E Kleiner; Kevin P High; Caryn G Morse
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

6.  Drug associated vanishing bile duct syndrome combined with hemophagocytic lymphohistiocytosis.

Authors:  Hui Li; Xin Li; Xiao-Xing Liao; Hong Zhan; Yan Xiong; Chun-Lin Hu; Hong-Yan Wei; Xiao-Li Jing
Journal:  World J Gastrointest Endosc       Date:  2012-08-16

Review 7.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

8.  Structural and functional implications of the interaction between macrolide antibiotics and bile acids.

Authors:  Simon Glanzer; Sergio A Pulido; Sarah Tutz; Gabriel E Wagner; Manfred Kriechbaum; Nina Gubensäk; Jovana Trifunovic; Markus Dorn; Walter M F Fabian; Predrag Novak; Joachim Reidl; Klaus Zangger
Journal:  Chemistry       Date:  2015-02-05       Impact factor: 5.236

9.  Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.

Authors:  Wen Xie; Qi Wang; Yuanjiao Gao; Calvin Q Pan
Journal:  BMC Gastroenterol       Date:  2018-09-29       Impact factor: 3.067

Review 10.  Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver.

Authors:  Sandeep Satsangi; Nitin Gupta; Parul Kodan
Journal:  J Clin Transl Hepatol       Date:  2021-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.